EJCTS Click here to go to Siemens website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riquet, M.
Right arrow Articles by Debesse, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riquet, M.
Right arrow Articles by Debesse, B.

European Journal of Cardio-Thoracic Surgery, Vol 11, 440-443, Copyright © 1997 by European Association for Cardio-thoracic Surgery


ARTICLES

Prognostic value of T and N in non small cell lung cancer three centimeters or less in diameter

M Riquet, D Manac'h, F Le Pimpec Barthes, A Dujon, D Debrosse and B Debesse
Service de Chirurgie thoracique, Hopital Laennec, Paris, France.

OBJECTIVE: Peripheral tumors 3 cm or less in diameter are classified T1, T2 when rupturing the visceral pleura, T3 when invading parietal pleura, chest wall, mediastinal pleura or pericardium and T4 when invading vertebra or mediastinal structures. Our objective was to assess the prognostic significance of T and N status according to the size of such tumors. PATIENTS AND METHODS: Patients (918) were operated upon between April 1984 and December 1991. Surgery included complete resection and mediastinal lymphadenectomy. Tumors 3 cm or less were studied concerning T, N status, histology and survival. RESULTS: There were 314 such tumors (T1 = 215, T2 = 64, T3 = 35, T4 = 6); N status was N0 60.2%, N1 21%, N2 18.8%. Global 5-year survival was 52.59%. In case of N0, survival was 64.63%: T1 = 63.76%, T2 = 71.48%, T3 = 45.71%, T4 = 66.6%; which was not significant. There were 48 tumors 1.0 cm or less in diameter (G1), 111 tumors 1.1-2.0 cm in diameter (G2) and 155 tumors 2.1-3 cm in diameter (G3). The incidence of N0, N1 and N2 disease was 77.1, 10.4 and 12.5%, respectively in G1, 64, 18 and 18% in G2, and 52.3, 26.5 and 21.3% in G3. The 5-year survival rate was 62.46% for G1, 52.91% for G2 and 49.36% for G3 (NS). In cases of N1 and N2, survival was 48.41% and 20.2% which was significant (P < 0.05) but differences between each T and each G were not significant. CONCLUSIONS: Small peripheral cancers spread into mediastinal nodes in 12.5-21.3% of cases, according to the size. This is a warning to perform nodes resections in cases where surgeons intend a videothoracoscopic approach. N2 status is not only an indicator but also a governor of prognosis. Neither T status nor size are determinants of prognosis as far as tumors 3 cm in diameter or less are concerned.


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
N. K. Veeramachaneni, R. J. Battafarano, B. F. Meyers, J. B. Zoole, and G. A. Patterson
Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival
Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 466 - 469.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Massard, X. Ducrocq, E. A. Kochetkova, V. A. Porhanov, and M. Riquet
Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study.
Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 164 - 167.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
The International Early Lung Cancer Action Program
Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size.
Arch Intern Med, February 13, 2006; 166(3): 321 - 325.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. B. Flieder, J. L. Port, R. J. Korst, P. J. Christos, M. A. Levin, D. E. Becker, and N. K. Altorki
Tumor Size Is a Determinant of Stage Distribution in T1 Non-Small Cell Lung Cancer
Chest, October 1, 2005; 128(4): 2304 - 2308.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. P. Wisnivesky, D. Yankelevitz, and C. I. Henschke
The Effect of Tumor Size on Curability of Stage I Non-small Cell Lung Cancers
Chest, September 1, 2004; 126(3): 761 - 765.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Myrdal, M. Lambe, G. Gustafsson, K. Nilsson, and E. Stahle
Survival in primary lung cancer potentially cured by operation: influence of tumor stage and clinical characteristics
Ann. Thorac. Surg., February 1, 2003; 75(2): 356 - 363.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Lopez-Encuentra, J. L. Duque-Medina, R. Rami-Porta, A. G. de la Camara, and P. Ferrando
Staging in Lung Cancer: Is 3 cm a Prognostic Threshold in Pathologic Stage I Non-small Cell Lung Cancer? : A Multicenter Study of 1,020 Patients
Chest, May 1, 2002; 121(5): 1515 - 1520.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Elia, S. Griffo, M. Gentile, R. Costabile, and G. Ferrante
Surgical treatment of lung cancer invading chest wall: a retrospective analysis of 110 patients
Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 356 - 360.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.